IMU 2.70% 3.6¢ imugene limited

Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results, page-88

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    Wow, truly amazing results!

    Better, in a statistically significant way, than SoC and original Herceptin Toga trial results. With no added toxicity.

    IMHO this is a treatment revolution.

    Congratulations to Leslie and team, amazing job.

    And how wonderful for the patients on this trial and in the future! Glad they have an improved outcome with her-vaxx.

    I'm glad they upped the dose, future looks even brighter.

    Well done LT holders.


    Last edited by DTshares: 27/06/22
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
3.6¢
Change
-0.001(2.70%)
Mkt cap ! $267.7M
Open High Low Value Volume
3.7¢ 3.7¢ 3.6¢ $206.0K 5.619M

Buyers (Bids)

No. Vol. Price($)
26 5828814 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 2691000 6
View Market Depth
Last trade - 14.10pm 25/12/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.